Participant flow32

How many started, completed or left each group, period by period.

1 to 20 of 32

Period	Milestone	Group	Participants
Primary Evaluation Period	STARTED	Ravulizumab/Ravulizumab	125
Primary Evaluation Period	STARTED	Eculizumab/Ravulizumab	121
Primary Evaluation Period	STARTED	Roll-Over Cohort: Ravulizumab - Adults	0
Primary Evaluation Period	STARTED	Roll-Over Cohort: Ravulizumab - Pediatrics	0
Primary Evaluation Period	Received at Least 1 Dose of Study Drug	Ravulizumab/Ravulizumab	125
Primary Evaluation Period	Received at Least 1 Dose of Study Drug	Eculizumab/Ravulizumab	121
Primary Evaluation Period	Received at Least 1 Dose of Study Drug	Roll-Over Cohort: Ravulizumab - Adults	0
Primary Evaluation Period	Received at Least 1 Dose of Study Drug	Roll-Over Cohort: Ravulizumab - Pediatrics	0
Primary Evaluation Period	COMPLETED	Ravulizumab/Ravulizumab	125
Primary Evaluation Period	COMPLETED	Eculizumab/Ravulizumab	119
Primary Evaluation Period	COMPLETED	Roll-Over Cohort: Ravulizumab - Adults	0
Primary Evaluation Period	COMPLETED	Roll-Over Cohort: Ravulizumab - Pediatrics	0
Primary Evaluation Period	NOT COMPLETED	Ravulizumab/Ravulizumab	0
Primary Evaluation Period	NOT COMPLETED	Eculizumab/Ravulizumab	2
Primary Evaluation Period	NOT COMPLETED	Roll-Over Cohort: Ravulizumab - Adults	0
Primary Evaluation Period	NOT COMPLETED	Roll-Over Cohort: Ravulizumab - Pediatrics	0
Extension Period	STARTED	Ravulizumab/Ravulizumab	124
Extension Period	STARTED	Eculizumab/Ravulizumab	119
Extension Period	STARTED	Roll-Over Cohort: Ravulizumab - Adults	24
Extension Period	STARTED	Roll-Over Cohort: Ravulizumab - Pediatrics	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02946463/flow